Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Med., 17 October 2025

Sec. Regulatory Science

Volume 12 - 2025 | https://doi.org/10.3389/fmed.2025.1710876

Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada

  • 1Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
  • 2Institut d'hématologie, oncologie et thérapie cellulaire (iHOT), Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
  • 3Département de médicine, Faculté de médecine, Université de Montréal, Montreal, QC, Canada
  • 4Québec Cell, Tissue and Gene Therapy Network, Montreal, QC, Canada
  • 5Transfusion Medicine, Héma-Québec, Montreal, QC, Canada
  • 6Centre of Genomics and Policy, Department of Human Genetics, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
  • 7Borealis Medical Writing Inc., Montreal, QC, Canada
  • 8Cancer Axis, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada
  • 9Department of Hepatopancreatobiliary Surgery and Liver Transplantation Service, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada
  • 10Axe santé des populations et pratiques optimales en santé, Centre de recherche du Centre hospitalier universitaire de Québec, Université Laval, Québec City, QC, Canada
  • 11Département de médecine sociale et préventive, Faculté de médecine, Université Laval, Québec City, QC, Canada
  • 12Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Québec City, QC, Canada
  • 13Laboratoire de bio-ingénierie et de biophysique de l'Université de Sherbrooke, Department of Chemical and Biotechnological Engineering, Université de Sherbrooke, Sherbrooke, QC, Canada
  • 14Faculté de Médecine et des Sciences de la santé, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada
  • 15Centre de Recherche du CHU de Québec-Université Laval, Québec City, QC, Canada
  • 16Département de Médecine Moléculaire, Université Laval, Québec City, QC, Canada
  • 17adMare BioInnovations, Montreal, QC, Canada
  • 18Centre de Recherche du Centre hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada
  • 19Département de Pharmacologie et Physiologie, Faculté de Médecine, Université de Montréal, Montreal, QC, Canada
  • 20Centre C3i Inc., Montreal, QC, Canada
  • 21Division of Hematology, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada
  • 22BioCanRx, Ottawa, ON, Canada
  • 23Axe immunopathologie, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada
  • 24Département de microbiologie, Infectiologie et immunologie, Faculté de médecine, Université de Montréal, Montreal, QC, Canada
  • 25Héma-Québec, Medical Affairs and Innovation, Montreal, QC, Canada

A Correction on
Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada

by Delisle, J.-S., Fournier, D., Santerre, K., Rochette, S., Zawati, M. H., Dumont-Lagacé, M., Turcotte, S., Guertin, J. R., Vermette, P., Tremblay, J. P., Parisotto, M., Gélinas, J.-F., Beauséjour, C., Petropoulos, L., Kekre, N., Michaud, S., and Dieudé, M. (2025). Front. Med. 12:1581058. doi: 10.3389/fmed.2025.1581058

Author Jean-François Gélinas was omitted as an author in the published article.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. All authors agreed to the correction.

The corrected author list appears below (there are no changes to the affiliation list):

Jean-Sébastien Delisle1,2,3,4*, Diane Fournier5*, Kim Santerre4, Samuel Rochette5, Ma'n H. Zawati4.6, Maude Dumont-Lagacé5,7, Simon Turcotte4,8,9, Jason Robert Guertin4,10,11,12, Patrick Vermette4,13,14, Jacques P. Tremblay4,15,16, Maxime Parisotto17, Christian Beauséjour4,18,19, Jean-François Gélinas4,20 Louisa Petropoulos20, Natasha Kekre21, Stéphanie Michaud22, Mélanie Dieudé23,24,25*.

In the published article, the author contribution and conflict of interest statements were missing the information of author Jean-François Gélinas, who was erroneously excluded from the author list.

A correction has been made to the section Author Contributions to add the contributions of Jean-François Gélinas. The added sentence appears below:

“J-FG: Data curation, Formal analysis, Writing – review and editing.”

A correction has also been made to the section Conflict of Interest to add information on author Jean-François Gélinas. This sentence previously stated :

“LP was employed by Centre C3i Inc.”

The corrected sentence appears below:

“J-FG is and LP was employed by Centre C3i Inc.”

The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: immune effector cell immunotherapy, research funding, economic evaluation, ethics, biological drug approval, cell and tissue manufacturing

Citation: Delisle J-S, Fournier D, Santerre K, Rochette S, Zawati MH, Dumont-Lagacé M, Turcotte S, Guertin JR, Vermette P, Tremblay JP, Parisotto M, Beauséjour C, Gélinas J-F, Petropoulos L, Kekre N, Michaud S and Dieudé M (2025) Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada. Front. Med. 12:1710876. doi: 10.3389/fmed.2025.1710876

Received: 22 September 2025; Accepted: 29 September 2025;
Published: 17 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Delisle, Fournier, Santerre, Rochette, Zawati, Dumont-Lagacé, Turcotte, Guertin, Vermette, Tremblay, Parisotto, Beauséjour, Gélinas, Petropoulos, Kekre, Michaud and Dieudé. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jean-Sébastien Delisle, anMuZGVsaXNsZUB1bW9udHJlYWwuY2E=; Diane Fournier, ZGlhbmUuZm91cm5pZXJAaGVtYS1xdWViZWMucWMuY2E=; Mélanie Dieudé, bWVsYW5pZS5kaWV1ZGVAaGVtYS1xdWViZWMucWMuY2E=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.